These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 932494)

  • 1. Enhanced efficacy of amphotericin B and rifampicin combined in treatment of murine histoplasmosis and blastomycosis.
    Kitahara M; Kobayashi GS; Medoff G
    J Infect Dis; 1976 Jun; 133(6):663-8. PubMed ID: 932494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of histoplasmosis and blastomycosis.
    Saag MS; Dismukes WE
    Chest; 1988 Apr; 93(4):848-51. PubMed ID: 3280262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic histoplasmosis with oesophageal obstruction due to Histoplasma granulomas. Successful treatment with rifampicin and amphotericin B.
    Hull PR
    S Afr Med J; 1979 Apr; 55(16):639-40. PubMed ID: 462280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of blastomycosis and histoplasmosis in the dog.
    Ausherman RJ
    J Am Vet Med Assoc; 1973 Nov; 163(9):1048-9. PubMed ID: 4747901
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental chemotherapy of histoplasmosis in nude mice.
    Williams DM; Graybill JR; Drutz DJ
    Am Rev Respir Dis; 1979 Oct; 120(4):837-42. PubMed ID: 507510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal action of rifampin.
    Medoff G
    Rev Infect Dis; 1983; 5 Suppl 3():S614-9. PubMed ID: 6356283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative chemotherapeutic activity of amphotericin B and amphotericine B methy ester.
    Bonner DP; Tewari RP; Solotorovsky M; Mechlinski W; Schaffner CP
    Antimicrob Agents Chemother; 1975 Jun; 7(6):724-9. PubMed ID: 1155916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of neohepataene on experimental systemic mycoses in mice.
    Lones GW; Pggott WR; Hill WB
    Sabouraudia; 1968 Oct; 6(4):334-8. PubMed ID: 5726644
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of interferon-gamma and amphotericin B for the treatment of systemic murine histoplasmosis.
    Clemons KV; Lutz JE; Stevens DA
    Microbes Infect; 2001 Jan; 3(1):3-10. PubMed ID: 11226849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy with amphotericin B and caspofungin in an experimental model of disseminated histoplasmosis.
    Rodríguez-Arellanes G; Taylor ML; Pérez-Torres A; Curiel-Quesada E; Vargas-Mendoza CF; Martínez-Rivera MA
    Rev Invest Clin; 2009; 61(1):4-10. PubMed ID: 19507469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental canine histoplasmosis and blastomycosis.
    Ebert JW; Jones V; Jones RD; Weeks RJ; Tosh FE
    Mycopathol Mycol Appl; 1971 Dec; 45(3):285-300. PubMed ID: 5164388
    [No Abstract]   [Full Text] [Related]  

  • 12. [Systemic mycoses. 2. Systemic mycoses caused by dimorphous fungi (African histoplasmosis, blastomycosis, paracoccidioidomycosis,, sporotrichosis)].
    Meinhof W
    Fortschr Med; 1976 Sep; 94(26):1392-4. PubMed ID: 976915
    [No Abstract]   [Full Text] [Related]  

  • 13. Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infection.
    Haynes RR; Connolly PA; Durkin MM; LeMonte AM; Smedema ML; Brizendine E; Wheat LJ
    J Infect Dis; 2002 Jun; 185(12):1830-2. PubMed ID: 12085335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination of rifampicin with amphotericin B in the treatment of paracoccidioidomycosis. Results in 3 treated patients].
    Wanke B; Pedrosa PN; Brêtas GS; Setúbal S
    Rev Inst Med Trop Sao Paulo; 1984; 26(4):205-11. PubMed ID: 6522951
    [No Abstract]   [Full Text] [Related]  

  • 15. Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function.
    Burges JL; Birchall R
    Am J Med; 1972 Jul; 53(1):77-84. PubMed ID: 5037291
    [No Abstract]   [Full Text] [Related]  

  • 16. Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function.
    Burgess JL; Birchall R
    Am J Med; 1972 Jul; 53(1):77-84. PubMed ID: 4667504
    [No Abstract]   [Full Text] [Related]  

  • 17. Amphotericin B--specifics of administration.
    Goodman JS; Koenig MG
    Mod Treat; 1970 May; 7(3):581-95. PubMed ID: 4920806
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of canine blastomycosis with amphotericin B and ketoconazole.
    Legendre AM; Selcer BA; Edwards DF; Stevens R
    J Am Vet Med Assoc; 1984 May; 184(10):1249-54. PubMed ID: 6330013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing amphotericin B reactions. 3. Use of a preparation with increased phosphate buffer.
    Williams TW; Utz JP; Alling DW
    Am Rev Respir Dis; 1965 Dec; 92(6):963-5. PubMed ID: 5321054
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary blastomycosis in children. Amphotericin B therapy and a review.
    Chesney JC; Gourley GR; Peters ME; Moffet HL
    Am J Dis Child; 1979 Nov; 133(11):1134-9. PubMed ID: 583093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.